Globally, maternal deaths during pregnancy and postpartum are a public health crisis. In the United States, approximately 1,200 women die each year during childbirth and postpartum periods due to pregnancy related complications. Global, National, and State surveillance reports have deemed that 80% of these deaths are preventable. The U.S. maternal morbidity and mortality rates are the highest among industrialized nations worldwide. The current data suggests that this trend is worsening despite significant advancements in healthcare practices and technologies. The prevalence of near deaths far exceeds the maternal deaths and pose significant morbidity for women and infants. Access to care, implicit bias, and systemic racism are the leading causes of maternal health disparities. In addition, the maternity provider workforce supply is on average 5 to 6 times less in comparison to other developed countries who have low maternal mortality rates. This presentation will explore the history of maternal health disparities, causes of maternal deaths, and proposed solutions to address the maternal health crisis in the United States. | 1.50 CE/CME category 1 credits (0.50 Pharmacology) | $35

70% of US adults have obesity or pre-obesity and only 2% are offered pharmacology treatment as part of the evidenced based treatment. It is important for clinicians to know the full evidenced-based management of the disease of obesity. During this presentation the participant will review FDA approved medications and discuss off label options to assist with treatment. | 1.0 CE/CME category 1 credits (1.0 Pharmacology) | $35

This presentation offers a comprehensive exploration of Opioid Use Disorder (OUD), equipping nurse practitioners and healthcare professionals with essential tools to address this growing crisis. Attendees will gain a deeper understanding of the assessment and diagnosis of OUD using DSM-5-TR criteria, along with strategies for managing opioid intoxication, overdose, and withdrawal. The session will also cover evidence-based treatment options, both pharmacological and non-pharmacological, emphasizing a patient-centered approach. With a focus on practical application and current statistics, this engaging and informative talk will prepare participants to effectively recognize and treat OUD, ultimately improving patient outcomes. | 1.50 CE/CME category 1 credits (1.50 Pharmacology) | $40

This presentation examines strategies that health care providers can utilize to assess for and prevent suicide in the health care setting. The epidemiology of suicide will be briefly reviewed, and there will be a special discussion surrounding suicide among health care providers. This talk includes approaches to training office staff in suicide awareness and prevention. Safety planning, documentation, follow up, and self-care for the provider will be reviewed. The goal of this activity is to empower health care providers to confidently address suicide risk in their patient populations. | 1.50 CE/CME category 1 credits (1.0 Pharmacology) | $35

Using the concept of health equity participants will be able to understand how NP nursing leaders can improve the ways in which they help move society in a positive direction towards achieving health equity. This will include the importance of Justice, Equity, Diversity, and Inclusion in NP clinical work settings. | 1.0 CE/CME category 1 credits (0 Pharmacology) | $27.50

The purpose of this workshop is to provide NP’s an update on the treatment of patients with HIV. It will include an overview of the issues that have impacted the uptake and use of PrEP, PEP, the newest mediations available for treatment, and a brief discussion on the impact of the end the epidemic initiatives. |1.50 CE/CME category 1 credits (1.50 Pharmacology) | $40

This session discusses the impact obesity has on the overall health of a patient. The risks of obesity and the extreme benefits of weight loss in regard to malignancies, cardiac disease and many more. In depth discussion about the decreased life expectancy of the obese patient. The learner will have a new outlook on the overall diagnosis and treatment of obesity in the patient population. | 1.50 CE/CME category 1 credits (1.0 Pharmacology) | $35

This presentation will focus on the class of anxiolytics known as the benzodiazepines. Over the years, prescribers have had a love/hate relationship with these controlled substances. Upon completion of this presentation, participants will learn the benefits and risks related to the safe prescribing of benzodiazepines for individuals with various symptom presentations. The presentation will address the risks and cautions related to the prescribing of benzodiazepines with various medications, including the opioids and stimulants and in various healthcare settings. Participants also will receive tips to identify the warning signs of benzodiazepine abuse and techniques to safely taper and discontinue these medications to minimize the discomfort of withdrawal. | 1.0 CE/CME category 1 credits (1.0 Pharmacology) | $30

Preventing unintended pregnancy by providing the most effective contraceptive methods without barriers is more important then ever. Long-acting reversible contraception (LARC) is the safest and most effective contraception available. The implant and IUDs also have the highest patient satisfaction and continuation rates, and yet there remain many barriers to patients accessing these contraceptive methods. We will review common barriers and how to avoid them in your practice. We will discuss how to provide patient centered counselling about LARC methods, tools to provide the most up to date evidence-based care, and how to remove operational barriers in your practice. Whether you don’t provide LARC yet and want to hone your counseling skills and are interested in free training opportunities; or you are an experienced provider of LARC and want to update your practice and learn some helpful tips and tricks-There is something for everyone in this presentation. | 1.50 CE/CME category 1 credits (1.50 Pharmacology) | $40

Almost half of all pregnancies in the U.S. are unintended and 1 in 4 women will have an abortion in their lifetime. Despite losing the right to abortion, people still need them. We will examine the current landscape of abortion access post-Roe, how and where people are accessing abortion care and what resources you can offer your patients to help them access the care they need. You will gain an in depth understanding of medication abortion: various evidence-based regimens, delivery systems like telehealth, warnings signs of a complication, overall safety and efficacy, and management of common problems post-abortion. We will also examine the role of self-managed abortion in this new landscape and dispel common myths. This lecture will leave you feeling confident and equipped to advocate and care for your patients before and after an abortion regardless of where you or they live. | 1.50 CE/CME category 1 credits (1.0 Pharmacology) | $35